Literature DB >> 29156904

Does gender affect self-perceived pain in cancer patients? -A meta-analysis.

Yusuf Ahmed1, Marko Popovic1, Bo Angela Wan1, Michael Lam1, Henry Lam1, Vithusha Ganesh1, Milica Milakovic1, Carlo DeAngelis2, Leila Malek1, Edward Chow3.   

Abstract

BACKGROUND: Pain is reported in approximately 50-70% of cancer patients. Studies on gender differences in perceived pain generally report lower pain thresholds and increased pain prevalence in women, which may be attributed to gender-specific behaviors, stereotypes, and unknown etiological factors. There are sparse and inconclusive results on gender differences in self-perceived pain in the cancer setting. The aim of this article was to examine the effect of gender on baseline perceived pain intensity in cancer patients through a meta-analysis.
METHODS: A literature search was conducted using Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials [1947-2016] to identify observational studies and controlled trials that reported on gender-specific pain intensity in cancer patients. Using random-effects modeling, weighted mean differences and 95% confidence intervals (CI) were used to estimate the effect of gender on pain severity in cancer patients. A P value of less than 0.05 was considered statistically significant.
RESULTS: Of the 1,911 search results reviewed, 13 studies were included. The weighted mean difference (95% CI) in pain intensity was as follows: -0.26 (95% CI: -0.57 to 0.04, P=0.09) for the 0-10 Numerical Rating Scale (NRS) group (n=3,752, 9 studies). When restricted to only patients with advanced cancer, the weighted mean difference was -0.08 (95% CI: -0.36 to 0.20, P=0.58) (n=2,762, 4 studies). The weighted mean difference in the Brief Pain Inventory scores between males and females was 0.03 (95% CI: -1.23 to 1.29, P=0.96) (n=521, 4 studies).
CONCLUSIONS: Baseline perceived pain intensity in cancer patients did not significantly differ based on gender.

Entities:  

Keywords:  Cancer; gender difference; meta-analysis; pain; review

Mesh:

Year:  2017        PMID: 29156904     DOI: 10.21037/apm.2017.08.09

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  6 in total

1.  Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?

Authors:  Morten Thronæs; Trude Rakel Balstad; Cinzia Brunelli; Erik Torbjørn Løhre; Pål Klepstad; Ola Magne Vagnildhaug; Stein Kaasa; Anne Kari Knudsen; Tora Skeidsvoll Solheim
Journal:  Support Care Cancer       Date:  2019-07-09       Impact factor: 3.603

2.  Chronic pain following thoracotomy for lung surgeries: It's risk factors, prevalence, and impact on quality of life - A retrospective study.

Authors:  Prachi Kar; K Durga Sudheshna; Durga Padmaja; Archana Pathy; Ramachandran Gopinath
Journal:  Indian J Anaesth       Date:  2019-05

3.  Gender Difference in Pain Management Among Adult Cancer Patients in Saudi Arabia: A Cross-Sectional Assessment.

Authors:  Abdulaziz Alodhayani; Khalid M Almutairi; Jason M Vinluan; Norah Alsadhan; Turky H Almigbal; Wadi B Alonazi; Mohammed Ali Batais
Journal:  Front Psychol       Date:  2021-08-26

4.  Prevalence and Severity of Pain in Cancer Patients in Germany.

Authors:  Laura Broemer; Andreas Hinz; Uwe Koch; Anja Mehnert-Theuerkauf
Journal:  Front Pain Res (Lausanne)       Date:  2021-09-24

5.  Does Cancer Type Influence the Impact of Recurrence? A Review of the Experience of Patients With Breast or Prostate Cancer Recurrence.

Authors:  Ross James Stewart; Gerald Michael Humphris; Jayne Donaldson; Susanne Cruickshank
Journal:  Front Psychol       Date:  2021-06-29

6.  Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study.

Authors:  Arturo Cuomo; Marco Cascella; Cira Antonietta Forte; Sabrina Bimonte; Gennaro Esposito; Stefano De Santis; Luigi Cavanna; Flavio Fusco; Mario Dauri; Silvia Natoli; Marco Maltoni; Alessandro Morabito; Rocco Domenico Mediati; Vito Lorusso; Sandro Barni; Giampiero Porzio; Sebastiano Mercadante; Anna Crispo
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.